Щитовидная железа и сердце
https://doi.org/10.14341/ket20095337-42
Аннотация
Список литературы
1. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study // Arch. Intern. Med. 2000. V. 160. P. 526–530.
2. Biondi B., Palmieri E.A., Lombardi G., Fazio S. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism // J. Clin. Endocrinol. Metab. 2002. V. 87. P. 968–974.
3. Everts M.E., Verhoeven F.A., Bezstarosti K. et al. Uptake of thyroid hormones in neonatal rat cardiac myocytes // Endocrinol. 1996. V. 137. P. 4235–4242.
4. Klein I., Danzi S. Thyroid Disease and the Heart // Circulat. 2007. V. 116. P. 1725–1735
5. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system // N. Engl. J. Med. 2001. V. 344. P. 501–509.
6. Danzi S., Klein I. Thyroid hormone and the cardiovascular system // Minerva Endocrinologica. 2004. V. 29. P. 139–150.
7. Petersen P., Hansen J.M. Stroke in thyrotoxicosis with atrial fibrillation // Stroke. 1988. V. 19. P. 15–18.
8. Krahn A.D., Klein G.J., Kerr C.R. et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators // Arch. Intern. Med. 1996. V. 156. P. 2221–2224.
9. Duntas L.H. Thyroid disease and lipids. Thyroid. 2002. V. 12. P. 287–293.
10. Nakazawa H.K., Sakurai K., Hamada N., Momotani N., Ito K. Management of atrial fibrillation in the post-thyrotoxic state // Am. J. Med. 1982. V. 72. P. 903–906.
11. Gilligan D.M., Ellenbogen K.A., Epstein A.E. The management of atrial fibrillation // Am. J. Med. 1996. V. 101. P. 413–421.
12. Sawin C.T., Geller A., Wolf P.A. et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons // N. Engl. J. Med. 1994. V. 331. P. 1249–1252
13. Biondi B., Fazio S., Carella C. et al. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving longterm suppressive therapy with levothyroxine // J. Clin. Endocrinol. Metab. 1994. V. 78. P. 1028–1033.
14. Forfar J.C., Muir A.L., Sawers S.A., Toft A.D. Abnormal left ventricular function in hyperthyroidism: evidence for possible reversible cardiomyopathy // N. Engl. J. Med. 1982. V. 307. P. 1165–1170.
15. Шульгина В.Ю., Фадеев В.В., Мельниченко Г.А. Поражение миокарда при тиреотоксикозе: особенности течения, исходы, отдаленный прогноз // Клин. и экспер. тиреоидол. 2006. Т. 2. № 4. С. 21–30.
16. Kahaly G., Mohr-Kahaly S., Hellermann // J. Heart. Thyroid. Wien. 1994.
17. Kahaly G. Graves’ disease and mitral valve prolapse // JAMA. 1987. V. 257. P. 22–28.
18. Klein I., Ojamaa K. The cardiovascular system in hypothyroidism / In: L.E. Braverman, R.D. Utiger // Eds. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000. P. 777–782.
19. Bengel F.M., Nekolla S.G., Ibrahim T. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging // J. Clin. Endocrinol. Metab. 2000. V. 85. P. 1822–1827.
20. Ojamaa K., Sabet A., Kenessey A. et al. Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific // Endocrinol. 1999. V. 140. P. 3170–3176.
21. Cooper D., Halpern R., Wood L.C. et al. L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial // Ann. Intern. Med. 1984. V. 101. P. 18–24.
22. Hak A.E., Pols H.A.P, Visser T.J. et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study // Ann. Intern. Med. 2000. C. 132. P. 270–278.
23. Franklyn J.A., Gammage M.D., Ramsden D.B., Sheppard M.C. Thyroid status in patients after acute myocardial infarction // Clin. Sci (Colch). 1984. V. 67. P. 585–590.
24. Hamilton M.A., Stevenson L.W., Fonarow G.C. et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure // Am. J. Cardiol. 1998. V. 81. P. 443–447.
25. Moruzzi P., Doria E., Agostoni P.G. Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy // Am. J. Med. 1996. V. 101. P. 461–467.
26. Holland F.W., Brown P.S.Jr., Weintraub B.D., Clark R.E. Cardiopulmonary bypass and thyroid function: a “euthyroid sick syndrome” // Ann. Thorac. Surg. 1991. V. 52. P. 46–50.
27. Novitzky D., Fontanet H., Snyder M. et al. Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery // Cardiology. 1996. V. 87. P. 509–515.
28. Cimochowski G.E., Harostock M.D., Foldes P.J. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support // Thorac. Cardiovasc. Surg. 1997. V. 113. P. 655–666.
29. Klemperer J.D., Klein I.L., Ojamaa K. et al. Triiodothyronine therapy the incidence of atrial fibrillation after cardiac operations // Ann. Thorac. Lowers. Surg. 1996. V. 61. P. 1323–1329.
30. Mullis-Janson S.L., Argenziano M., Corwin S. et al. A randomized doubleblind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery // J. Thor. Cardiovasc. Surg. 1999. V. 117. P. 1128–1134.
31. Bennett-Guerrero E., Jimenez J.L., White W.D. et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: a randomized, doubleblind, placebo-controlled trial // JAMA. 1996. V. 275. P. 687–692.
32. Bettendorf M., Schmidt K.G., Tiefenbacher U. et al. Transient secondary hypothyroidism in children after cardiac surgery // Pediatr. Res. 1997. V. 41. P. 375–379.
33. Saatvedt K., Lindberg H. Depressed thyroid function following pediatric cardiopulmonary bypass: association with interleukin-6 release? Scand // J. Thorac. Cardiovasc. Surg. 1996. V. 30. P. 61–64.
34. Mainwaring R.D., Lamberti J.J., Carter T.L.Jr., Nelson J.C. Reduction in triiodothyronine levels following modified Fontan procedure // J. Card. Surg. 1994. V. 9. P. 322–331.
35. Chowdhury D., Parnell V., Ojamaa K. et al. Usefulness of triiodothyronine treatment after surgery for complex congenital heart disease in infants and children // Am. J. Cardiol. 1999. V. 84. P. 1107–1109.
Рецензия
Для цитирования:
Karas A., Obrezan A. Щитовидная железа и сердце. Клиническая и экспериментальная тиреоидология. 2009;5(3):37-42. https://doi.org/10.14341/ket20095337-42
For citation:
, Thyroid and the Heart. Clinical and experimental thyroidology. 2009;5(3):37-42. (In Russ.) https://doi.org/10.14341/ket20095337-42

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).